Backed by the University of Florida, Based in Science
MyRx pharmacogenetic testing is a service initiated by the University of Florida College of Pharmacy and the Center for Pharmacogenetics and Precision Medicine. MyRx was developed with the goal of improving patient outcomes through optimization of efficacy and limiting toxicity of drug therapy.
About the Center for Pharmacogenetics and Precision Medicine
Research in the Center for Pharmacogenetics and Precision Medicine spans from mechanistic studies to multi-omic approaches to elucidate genetic contributions to drug response. Center investigators collaborate with investigators across the University of Florida and other institutions, both nationally and internationally, to ensure innovation in this cutting-edge science.
The center also supports the UF Health Precision Medicine Program through the translation of pharmacogenomic research findings into patient care and examining outcomes with genotype-guided therapies.
Precision Medicine at the UF College of Pharmacy
Precision medicine means delivering the right treatments, at the right time, every time to the right person. It’s a promising idea that a growing number of UF Health patients benefit from thanks to scientific discoveries led by the UF Health Personalized Medicine Program.
Since launching in 2012, the program has led seven clinical implementations for gene-drug pairs, contributed to a growing evidence base in support of genotype-guided therapy and developed multiple education programs that are training current and future leaders in precision medicine. In addition, the UF College of Pharmacy operates the nation’s only training grant in genomic medicine and the only National Institutes of Health Implementing Genomics in Practice, or IGNITE, network site based in a pharmacy college.